What are treatment options for glioblastoma

Treatment Options for Glioblastoma

I understand you're looking for information about glioblastoma treatment. This is a serious diagnosis, and I want to provide you with clear, evidence-based information from trusted medical sources.

Understanding Glioblastoma

According to the NCCN (National Comprehensive Cancer Network) Guidelines, glioblastomas are fast-growing and aggressive grade 4 tumors—the most common and most dangerous type of malignant brain tumor in adults. They typically emerge as grade 4 tumors from the beginning and grow quickly, which is why prompt diagnosis and treatment are essential.

Primary Treatment Approach

1. Surgery (Tumor Resection)

The first step in treating glioblastoma is surgery to remove as much of the tumor as safely possible. The NCCN Guidelines explain that the main goal is to:

• Relieve pressure on the brain
• Achieve "maximal safe resection" (removing as much tumor as possible without damaging critical brain areas)

However, because glioblastoma cells invade deeply into surrounding brain tissue, removing the entire tumor isn't possible. This is why additional treatments are always needed.

Surgical options include:

• Maximal safe resection – removing as much tumor as safely possible, sometimes using awake surgery to protect critical brain functions
• Partial resection or biopsy – if complete removal isn't safe or feasible

In some cases, carmustine wafers (chemotherapy wafers) may be placed directly in the surgical cavity after tumor removal.

2. Additional (Adjuvant) Treatment

Because surgery alone cannot cure glioblastoma, the NCCN Guidelines strongly recommend additional treatment to destroy remaining tumor cells. NCCN experts highly recommend that people with glioblastoma consider a clinical trial as part of their treatment plan.

Standard Treatment Options by Age and Physical Condition

Treatment intensity varies based on your age and overall physical capability (called "performance status"). According to NCCN Guidelines, here are the main approaches:

For Adults Under Age 70 with Good Physical Capability:

The most common options include:

1. Radiation therapy and temozolomide chemotherapy given together, followed by more temozolomide chemotherapy plus tumor treating fields (TTFields)

2. Radiation therapy and temozolomide chemotherapy given together, followed by more temozolomide chemotherapy

3. Radiation therapy and lomustine/temozolomide chemotherapy given together, followed by more lomustine/temozolomide chemotherapy

4. Radiation therapy alone

5. Clinical trial participation (strongly recommended)

For Adults Under Age 70 with Limited Physical Capability:

Less intense options may include:

• Hypofractionated radiation therapy (larger doses in fewer sessions) with or without temozolomide
• Temozolomide chemotherapy only
• Supportive (palliative) care
• Clinical trial participation

For Adults Over Age 70 with Good Physical Capability:

Modified treatment options include:

• Hypofractionated radiation therapy and temozolomide given together, followed by more temozolomide
• Radiation therapy and temozolomide given together, followed by temozolomide plus TTFields
• Temozolomide chemotherapy only
• Hypofractionated radiation therapy only
• Clinical trial participation

For Adults Over Age 70 with Limited Physical Capability:

Less aggressive treatment that minimizes side effects:

• Hypofractionated radiation therapy only
• Temozolomide chemotherapy only
• Supportive care
• Clinical trial participation

Important Biomarkers That Guide Treatment

According to NCCN Guidelines, certain biomarkers in your tumor can help predict how well treatments will work:

• MGMT promoter methylation – Nearly half of glioblastomas have this biomarker. A glioblastoma with a methylated MGMT promoter tends to respond better to temozolomide chemotherapy and leads to longer survival compared to one with an unmethylated MGMT promoter.

Your treatment team will test your tumor for these biomarkers to help personalize your treatment plan.

Follow-Up Care

After treatment, you'll need regular MRI scans to monitor the glioblastoma. According to NCCN Guidelines, scans are typically scheduled:

• Every 2 to 4 months initially
• Then 3 to 6 times a year if there's no recurrence

These scans also monitor your brain health and identify any side effects from treatment.

If the Tumor Comes Back

The NCCN Guidelines acknowledge that glioblastoma will likely come back or continue to grow despite treatment. Treatment options for recurrent glioblastoma include:

• Clinical trials
• Chemotherapy
• Radiation therapy plus chemotherapy
• Targeted therapy
• TTFields (tumor treating fields)
• Supportive care

Important Considerations

Quality of Life: According to NCCN Guidelines, your quality of life should be the main priority guiding your treatment and care. Successful treatment isn't just about reducing the cancer—it includes minimizing cognitive problems, reducing pain, lowering anxiety and stress, and maintaining your ability to enjoy life.

Clinical Trials: The NCCN strongly emphasizes that anyone with glioblastoma should consider participating in a clinical trial, as these may offer access to newer, potentially more effective treatments.

Next Steps

I strongly encourage you to:

1. Discuss all these options with your multidisciplinary treatment team
2. Ask about clinical trials available at your treatment center
3. Request biomarker testing of your tumor (especially MGMT promoter status)
4. Consider getting a second opinion at a comprehensive cancer center

Remember, while glioblastoma is a serious diagnosis, treatment approaches continue to improve, and many people are living longer than previous statistics suggested.

Please consult with your healthcare providers to determine the best treatment plan for your specific situation. Every person's case is unique, and your medical team can tailor these options to your individual needs.